Article

Finite element analysis of stent deployment: understanding stent fracture in percutaneous pulmonary valve implantation.

UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, United Kingdom.
Journal of Interventional Cardiology (impact factor: 1.18). 01/2008; 20(6):546-54. DOI:10.1111/j.1540-8183.2007.00294.x
Source: PubMed

ABSTRACT To analyze factors responsible for stent fracture in percutaneous pulmonary valve implantation (PPVI) by finite element method.
PPVI is an interventional catheter-based technique for treating significant pulmonary valve disease. Stent fracture is a recognized complication.
Three different stent models were created: (1) platinum-10% iridium alloy stent - resembles the first-generation PPVI device; (2) same geometry, but with the addition of gold over the strut intersections - models the current stent; (3) same design as 1, but made of thinner wire. For Model 3, a stent-in-stent solution was applied. Numerical analyses of the deployment of these devices were performed to understand the stress distribution and hence stent fracture potential.
Model 1: Highest stresses occurred at the strut intersections, suggesting that this location may be at highest risk of fracture. This concurs with the in vivo stent fracture data. Model 2: Numerical analyses indicate that the stresses are lower at the strut intersections, but redistributed to the end of the gold reinforcements. This suggests that fractures in this device may occur just distal to the gold. This is indeed the clinical experience. Model 3 was weakest at bolstering the implantation site; however, when two stents were coupled (stent-in-stent technique), better strength and lower stresses were seen compared with Model 1 alone.
Using finite element analysis of known stents, we were able to accurately predict stent fractures in the clinical situation. Furthermore, we have demonstrated that a stent-in-stent technique results in better device performance, which suggests a novel clinical strategy.

0 0
 · 
1 Bookmark
 · 
40 Views
  • Article: Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.
    [show abstract] [hide abstract]
    ABSTRACT: Valved conduits from the right ventricle to the pulmonary artery are frequently used in paediatric cardiac surgery. However, stenosis and insufficiency of the conduit usually occur in the follow-up and lead to reoperations. Conduit stenting can delay surgical replacement, but it aggravates pulmonary insufficiency. We developed an innovative system for percutaneous stent implantation combined with valve replacement. A 12-year-old boy with stenosis and insufficiency of a prosthetic conduit from the right ventricle to the pulmonary artery underwent percutaneous implantation of a bovine jugular valve in the conduit. Angiography, haemodynamic assessment, and echocardiography after the procedure showed no insufficiency of the implanted valve, and partial relief of the conduit stenosis. There were no complications after 1 month of follow-up, and the patient is presently in good physical condition. We have shown that percutaneous valve replacement in the pulmonary position is possible. With further technical improvements, this new technique might also be used for valve replacement in other cardiac and non-cardiac positions.
    The Lancet 11/2000; 356(9239):1403-5. · 38.28 Impact Factor
  • Article: Stenting of coarctation of the aorta.
    [show abstract] [hide abstract]
    ABSTRACT: The purpose of the present study was to assess the usefulness of balloon expandable Palmaz intravascular stents in the transcatheter treatment of children and young adults with native and recurrent coarctation of the aorta, and to develop an improved intravascular stent and balloon delivery catheter specifically developed for vascular obstructions associated with congenital heart disease, including coarctation of the aorta. Twenty-one patients, 8 native and 13 recurrent coarctations, were successfully treated with the Palmaz stent. However, limitations and disadvantages in stent design and the single balloon delivery system were uncovered. Therefore, the NuMED CP stent and BIB delivery catheter were developed and used to treat 25 patients with native (17) and recurrent (8) coarctation successfully. Improvements in stent design and long-term follow-up using three-dimensional spiral CT scan will be helpful in determining the role of transcatheter stent therapy for native and recurrent coarctation of the aorta. Cathet Cardiovasc Intervent 2001;54:112-125.
    Catheterization and Cardiovascular Interventions 10/2001; 54(1):112-25. · 2.29 Impact Factor
  • Article: Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results.
    [show abstract] [hide abstract]
    ABSTRACT: Right ventricle-to-pulmonary artery (RV-PA) homografts and bioprosthetic conduits are commonly used to palliate various types of complex congenital heart disease. These conduits frequently develop progressive obstruction and require surgical replacement. This report reviews our experience implanting balloon-expandable stents to relieve conduit obstruction and delay reoperation. A retrospective review identified 44 patients who underwent placement of 48 stents in obstructed RV-PA conduits. Median patient age was 6.9 years (range, 7 months to 30 years), and median follow-up time was 14.2 months (range, 0 to 48 months). Stent implantation initially decreased the RV-PA pressure gradient from 61.0 +/- 16.9 to 29.7 +/- 11.9 mm Hg (P < or = .001) and the right ventricular-to-systemic arterial pressure ratio from 0.92 +/- 0.17 to 0.63 +/- 0.20 (P < or = .001). The diameter of the stenotic region expanded from 9.3 +/- 3.5 to 12.3 +/- 3.3 mm in the anteroposterior view (P < or = .001) and from 6.6 +/- 2.9 to 10.9 +/- 2.5 mm in the lateral view (P < or = .001). During the follow-up period, 2 patients had their stents redilated, 7 had additional conduit stents deployed, and 14 underwent surgical replacement of their conduits. Actuarial freedom from conduit reoperation was 65% at 30 months postprocedure. Seven patients were found to have fractured stents on follow-up, suggesting an important role for external compressive forces in conduit failure. Recatheterization in 16 patients a median of 11.8 months (3 to 48 months) postprocedure demonstrated hemodynamic evidence of recurrent obstruction despite sustained enlargement at the previously stented sites. Complications included stent displacement (n = 1), bacterial endocarditis (n = 1), and false aneurysm formation (n = 1). One patient died awaiting conduit replacement surgery. Stent implantation in obstructed RV-PA conduits results in significant immediate hemodynamic and angiographic improvement. In a subgroup of patients, the procedure prolongs conduit life span by several years and increases the interval between conduit reoperations. Recurrent obstruction is caused by external compression and progressive stenosis outside the stented region.
    Circulation 01/1996; 92(11):3282-8. · 14.74 Impact Factor

Full-text

View
2 Downloads
Available from
4 Jan 2013

Keywords

clinical experience
 
current stent
 
different stent models
 
factors responsible
 
finite element analysis
 
finite element method
 
gold reinforcements
 
highest risk
 
Highest stresses
 
implantation site
 
lower stresses
 
percutaneous pulmonary valve implantation
 
recognized complication
 
Stent fracture
 
stent fracture potential
 
stent fractures
 
stent-in-stent solution
 
stent-in-stent technique results
 
stress distribution
 
vivo stent fracture data